Spyridon Arampatzis

Dr. Spyridon Arampatzis


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2016 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
APAndreas Pasch
Andreas Pasch
GBGeoffrey A. Block
Geoffrey A. Block
MBMatthias Bachtler
Matthias Bachtler
ESEdward R. Smith
Edward R. Smith
WJWilhelm Jahnen-Dechent
Wilhelm Jahnen-Dechent
JFJuergen Floege
Juergen Floege
Background and objectives: Patients receiving hemodialysis are at risk of cardiovascular events. A novel blood test (T 50 test) determines the individual calcification propensity of blood. Design, setting, participants, & measurements: T 50 was determined in 2785 baseline serum samples of patients receiving hemodialysis enrolled in the Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE) trial and the T 50 results were related to patient outcomes. Results: Serum albumin, bicarbonate, HDL cholesterol, and creatinine were the main factors positively/directly and phosphate was the main factor negatively/inversely associated with T 50. The primary composite end point (all-cause mortality, myocardial infarction [MI], hospitalization for unstable angina, heart failure, or peripheral vascular event [PVE]) was reached in 1350 patients after a median follow-up time of 619 days. After adjustments for confounding, a lower T 50 was independently associated with a higher risk of the primary composite end point as a continuous measure (hazard ratio [HR] per 1 SD lower T 50, 1.15; 95% confidence interval [95% CI], 1.08 to 1.22; P<0.001). Furthermore, lower T 50 was associated with a higher risk in all-cause mortality (HR per 1 SD lower T 50, 1.10; 95% CI, 1.02 to 1.17; P=0.001), MI (HR per 1 SD lower T 50, 1.38; 95% CI, 1.19 to 1.60; P<0.001), and PVE (HR per 1 SD lower T 50, 1.22; 95% CI, 1.05 to 1.42; P=0.01). T 50 improved risk prediction (integrated discrimination improvement and net reclassification improvement, P<0.001 and P=0.001) of the primary composite end point. Conclusions: Blood calcification propensity was independently associated with the primary composite end point, all-cause mortality, MI, and PVE in the EVOLVE study and improved risk prediction. Prospective trials should clarify whether T 50-guided therapies improve outcomes.

1 November 2012 in The American Journal of Medicine
Verified
Journal Article
Closed access
SASpyridon Arampatzis
Spyridon Arampatzis
BFBettina Frauchiger
Bettina Frauchiger
GFGeorg-Martin Fiedler
Georg-Martin Fiedler
ALAlexander Benedikt Leichtle
Alexander Benedikt Leichtle
DBDaniela Buhl
Daniela Buhl
GLGregor Lindner
Gregor Lindner

1 January 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
CKCharlotte A. Keyzer
Charlotte A. Keyzer
MBMartin De Borst
Martin De Borst
EBElse van Den Berg
Else van Den Berg
WJWilli Jahnen-Dechent
Willi Jahnen-Dechent
SASpyridon Arampatzis
Spyridon Arampatzis
APAndreas Pasch
Andreas Pasch
Calciprotein particle maturation time (T50) in serum is a novel measure of individual blood calcification propensity. To determine the clinical relevance of T50 in renal transplantation, baseline serum T50 was measured in a longitudinal cohort of 699 stable renal transplant recipients and the associations of T50 with mortality and graft failure were analyzed over a median follow-up of 3.1 years. Predictive value of T50 was assessed for patient survival with reference to traditional (Framingham) risk factors and the calcium-phosphate product. Serum magnesium, bicarbonate, albumin, and phosphate levels were the main determinants of T50, which was independent of renal function and dialysis vintage before transplant. During follow-up, 81 (12%) patients died, of which 38 (47%) died from cardiovascular causes. Furthermore, 45 (6%) patients developed graft failure. In fully adjusted models, lower T50 values were independently associated with increased all-cause mortality (hazard ratio, 1.43; 95% confidence interval, 1.11 to 1.85; P=0.006 per SD decrease) and increased cardiovascular mortality (hazard ratio, 1.55; 95% confidence interval, 1.04 to 2.29; P=0.03 per SD decrease). In addition to age, sex, and eGFR, T50 improved prognostication for all-cause mortality, whereas traditional risk factors or calcium-phosphate product did not. Lower T50 was also associated with increased graft failure risk. The associations of T50 with mortality and graft failure were confirmed in an independent replication cohort. In conclusion, reduced serum T50 was associated with increased risk of all-cause mortality, cardiovascular mortality, and graft failure and, of all tested parameters, displayed the strongest association with all-cause mortality in these transplant recipients.

14 March 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RKRobert Kenward
Robert Kenward
MWM. J. Whittingham
M. J. Whittingham
SASpyridon Arampatzis
Spyridon Arampatzis
BMB. D. Manos
B. D. Manos
THThomas Hahn
Thomas Hahn
CRChristian Rutz
Christian Rutz
Conservation scientists, national governments, and international conservation groups seek to devise, and implement, governance strategies that mitigate human impact on the environment. However, few studies to date have systematically investigated the performance of different systems of governance in achieving successful conservation outcomes. Here, we use a newly-developed analytic framework to conduct analyses of a suite of case studies, linking different governance strategies to standardized scores for delivering ecosystem services, achieving sustainable use of natural resources, and conserving biodiversity, at both local and international levels. Our results: ( i ) confirm the benefits of adaptive management; and ( ii ) reveal strong associations for the role of leadership. Our work provides a critical step toward implementing empirically justified governance strategies that are capable of improving the management of human-altered environments, with benefits for both biodiversity and people.

27 March 2013 in BMC Medicine
Verified
Journal Article
Open access
PDF file
SASpyridon Arampatzis
Spyridon Arampatzis
GFGeorg-Christian Funk
Georg-Christian Funk
ALAlexander Benedikt Leichtle
Alexander Benedikt Leichtle
GFGeorg Martin Fiedler
Georg Martin Fiedler
CSChristoph Schwarz
Christoph Schwarz
GLGregor Lindner
Gregor Lindner
Background: Diuretics are among the most commonly prescribed medications and, due to their mechanisms of action, electrolyte disorders are common side effects of their use. In the present work we investigated the associations between diuretics being taken and the prevalence of electrolyte disorders on admission as well as the impact of electrolyte disorders on patient outcome. Methods: In this cross sectional analysis, all patients presenting between 1 January 2010 and 31 December 2011 to the emergency room (ER) of the Inselspital, University Hospital Bern, Switzerland were included. Data on diuretic medication, baseline characteristics and laboratory data including electrolytes and renal function parameters were obtained from all patients. A multivariable logistic regression model was performed to assess the impact of factors on electrolyte disorders and patient outcome. Results: A total of 8.5% of patients presenting to the ER used one diuretic, 2.5% two, and 0.4% three or four. In all, 4% had hyponatremia on admission and 12% hypernatremia. Hypokalemia was present in 11% and hyperkalemia in 4%. All forms of dysnatremia and dyskalemia were more common in patients taking diuretics. Loop diuretics were an independent risk factor for hypernatremia and hypokalemia, while thiazide diuretics were associated with the presence of hyponatremia and hypokalemia. In the Cox regression model, all forms of dysnatremia and dyskalemia were independent risk factors for in hospital mortality. Conclusions: Existing diuretic treatment on admission to the ER was associated with an increased prevalence of electrolyte disorders. Diuretic therapy itself and disorders of serum sodium and potassium were risk factors for an adverse outcome.

1 August 2002 in Chest
Verified
Journal Article
Closed access
JFJoachim Fichter
Joachim Fichter
DBDirk Bauer
Dirk Bauer
SASpyridon Arampatzis
Spyridon Arampatzis
RFRoland Fries
Roland Fries
AHArmin Heisel
Armin Heisel
GSGerhard Walter Sybrecht
Gerhard Walter Sybrecht